Response to comment on "Advantage of the protein-subunit SARS-CoV-2 vaccines, MVC-CoV1901 and NVX-CoV2373". - Lai PH; Hsieh SC (Journal of the Formosan Medical Association = Taiwan yi zhi, 2026)